Supplement-Drug Interactions Common in Lupus Patients, Study Finds
A study of 451 adults with systemic lupus erythematosus revealed that approximately 80% used at least one dietary supplement and nearly one-third were taking supplement-medication combinations with potential for harmful interactions. Vitamin D, multivitamins, and calcium were the most frequently used supplements, with older patients and those taking multiple medications at higher risk for interactions. Researchers emphasize that healthcare providers should routinely assess supplement use in lupus patients to prevent adverse effects.
The research involved adults enrolled in a longitudinal study examining aging experiences among lupus patients. Researchers systematically documented which over-the-counter and dietary products participants were consuming alongside their prescribed medications, then cross-referenced these combinations against established pharmacological interaction databases. The analysis revealed clear patterns: patients taking five or more prescription drugs simultaneously showed markedly higher rates of problematic supplement-medication pairings compared to those on fewer medications.
Vitamin D supplementation emerged as particularly prevalent in this population, likely reflecting both the disease's effects on bone health and general clinical recommendations. The finding that approximately 56% of participants used multiple supplements simultaneously suggests that patients may view these products as independently safe without considering cumulative effects or interactions with their lupus medications.
This research could prompt rheumatology practices to implement more systematic screening protocols around supplement use during patient consultations. Healthcare providers may face increased burden in tracking and counseling about interactions, particularly for older lupus patients managing complex medication regimens. Conversely, better-informed clinical practices could reduce preventable adverse events and hospitalizations. The findings may also influence how lupus patients approach over-the-counter products, potentially creating opportunities for patient education initiatives within rheumatology clinics.